Mentalization-oriented psychodynamic group therapy for patients with personality disorders: a naturalistic prospective cohort study.
Bo Anton SvenssonJacob BredtoftElsebeth StenagerPia Veldt LarsenLotte SkøtChristian SibbersenAngelina Isabella MellentinPublished in: Nordic journal of psychiatry (2022)
Completers improved on symptom severity, interpersonal problems, and general functioning, with within-group effect sizes ranging from medium to large. Approximately half the sample dropped out, suggesting that mentalization-oriented PDT spanning several years may be unrealistic for many patients with PD. Significant outcomesThere are no clear guidelines for psychological interventions targeting personality disorders (PDs), and currently eclectic and non-manualized psychodynamic approaches lasting for up to 3 years are prevailing in some clinical practices.Although this treatment approach may have an effect on compliant patients, the high drop-out rate indicates that it may not be suitable for a large proportion of PD patients since it requires long-term commitment. Furthermore, it is difficult to identify the content of the non-manualized psychodynamic therapy and what helps the patients.More specific clinical guidelines emphasizing the application of evidence-based treatments or at least manualized treatments are warranted for the treatment of emotionally unstable PDs and other PDs. LimitationsThe naturalistic study design, without any control group, limits conclusions about mechanisms of action of the intervention.Since the intervention was not manualized, it is unknown exactly which treatment was actually administered, which reduces external validity.The outcomes are based on completer data of a relatively small sample size with high drop-out rate.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- prognostic factors
- healthcare
- primary care
- metabolic syndrome
- machine learning
- patient reported outcomes
- mental health
- depressive symptoms
- photodynamic therapy
- bone marrow
- insulin resistance
- combination therapy
- mesenchymal stem cells
- drug delivery
- clinical practice
- cancer therapy